- HZNP has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $88.4 million
- HZNP is down 2.4% today from today's close
EXCLUSIVE OFFER: Get the inside scoop on opportunities in HZNP with the Ticky from Trade-Ideas. See the FREE profile for HZNP NOW at Trade-Ideas More details on HZNP: Horizon Pharma plc, a specialty biopharmaceutical company, engages in identifying, developing, acquiring or in-licensing, and commercializing medicines for the treatment of arthritis, pain, inflammatory, and/or orphan diseases in the United States and internationally. Currently there are nine analysts that rate Horizon Pharma a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Horizon Pharma has been 4 million shares per day over the past 30 days. Horizon has a market cap of $5.11 billion and is part of the health care sector and drugs industry. The stock has a beta of 2.26 and a short float of 10.9% with 4.37 days to cover. Shares are up 159.3% year-to-date as of the close of trading on Thursday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.